ASCO 2026 -Data Highlights From Oncology’s Biggest Event: BI Replay

On Demand

Duration: 65 Minutes

Original Date: June 03, 2026

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join Bloomberg Intelligence senior analysts Sam Fazeli, Max Nisen and the disease specialist team to review key takeaways from the 2026 ASCO conference in Chicago on May 29-June 2. The team will distill potentially practice-changing Phase III trial results including groundbreaking full results for Revolution Medicine's Daraxonrasib in pancreatic cancer, pivotal lung cancer data for PD-1/VEGF standard-setter ivonescimab and multiple datasets for Bristol Myers Squibb tentpole ADC Iza-bren.

ASCO 2026 -Data Highlights From Oncology’s Biggest Event: BI Replay

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.